Tempest Therapeutics (TPST) Earnings Date & Reports

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

TPST is expected to report earnings to fall 17.10% to -25 cents per share on May 08

Tempest Therapeutics TPST Stock Earnings Reports

Q1'25

Est.

$-0.26

Q4'24

Missed

by $0.06

Q3'24

Missed

by $0.05

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.04

The last earnings report on March 27 showed earnings per share of -31 cents, missing the estimate of -25 cents. With 1.44M shares outstanding, the current market capitalization sits at 27.93M.

View a ticker or compare two or three

Compare

TPST